Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Idiopathic Multicentric Castleman Disease Interactive Disease Awareness and Educational Tool for Pathologists

Elena Sabattini, Jadee Neff, Daisy Alapat, Thomas Tousseyn, Grzegorz Rymkiewicz, Henrique Moura de Paula, Kateřina Kamarádová, Santiago Montes Moreno, Stephen Lade

Blood (2022) 140 (Supplement 1): 13033–13034.

https://doi.org/10.1182/blood-2022-169712

Published: 2022

Journal Articles

Inhibition of PIM Kinases in Diffuse Large B-Cell Lymphoma Cells Targets MYC-Dependent Transcriptional Program, Increases CD20 Expression and Augments the Efficacy of Anti-CD20 Antibodies

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-134778

Published: 2020

Journal Articles

Niveau, a Phase 3 Study for Pts with B- or T-Cell Aggressive Non-Hodgkin Lymphoma in First Relapse or Progression Not Eligible for High-Dose Chemotherapy (HDT), Testing Nivo lumab in Combination with G e mcitabine, Ox a liplatin (GemOx), Plus Rit u ximab (R) in Case of B-Cell Lymphoma

Blood (2019) 134 (Supplement_1): 5311.

https://doi.org/10.1182/blood-2019-129362

Published: 2019

Journal Articles

The whole-genome landscape of Burkitt lymphoma subtypes

Blood (2019) 134 (19): 1598–1607.

https://doi.org/10.1182/blood.2019001880

Published: 2019

Includes: Supplemental data

Journal Articles

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1 − mantle cell lymphoma

Blood (2019) 133 (9): 940–951.

https://doi.org/10.1182/blood-2018-07-862151

Published: 2019

Includes: Supplemental data

Journal Articles

The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma

Blood (2019) 133 (9): 962–966.

https://doi.org/10.1182/blood-2018-07-864025

Published: 2019

Includes: Supplemental data

Journal Articles

Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

Francesco d'Amore, MD, Sirpa Leppä, MD, Maria Gomes da Silva, MD PhD, Thomas Relander, Grete Fossum Lauritzsen, Peter De Nully Brown, Antonio Pezzutto, Jeanette K. Doorduijn, MD PhD, Eckhart Weidmann, Michel van Gelder, Achiel Van Hoof, Ilse Christiansen, Unn Merete Fagerli, MD PhD, Hans Hagberg, MD, P.J. Lugtenburg, Jan Walewski, Ka Lung Wu, Hilde Maria Demuynck, Rob Fijnheer, Jacob H. Christensen, Milada Jankovská, MD, Pär L. Josefsson, Hanneke Kluin-Nelemans, Jose Mario Mariz, MD, Mats A. Merup, Thomas Noesslinger, Eric Van Den Neste, Josée M Zijlstra, MD, Georg Hopfinger, MD, VIT Prochazka, MD, Esa Jantunen, MD PhD, Ludmila Boudova, Jose Cabecadas, Andreas Chott, Jan M.A. Delabie, MD PhD, Laurence de Leval, MD, Arjan Diepstra, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Peter Noergaard, Andreas Rosenwald, Grzegorz Rymkiewicz, Christer Sundström, Lorenz Truemper, MD, Gerald Wulf, MD, Lauren Chong, MSc, Alyssa Bouska, PhD, Lynette Smith, Christian Gisselbrecht, Marita Ziepert, PhD, Markus Loeffler, MD, Knut Liestol, Christian Steidl, MD, Randy D. Gascoyne, MD, David W. Scott, PhDMD,FRACP,FRCPA, Bettina Altmann, PhD, Javeed Iqbal, §, Wing C Chan, MD, Helle Toldbod, MS,PhD

Blood (2018) 132 (Supplement 1): 998.

https://doi.org/10.1182/blood-2018-99-110429

Published: 2018

Journal Articles

Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network

Sietse M. Aukema, Eva Hoster, Andreas Rosenwald, Danielle Canoni, Marie-Hélène Delfau-Larue, Grzegorz Rymkiewicz, Christoph Thorns, Sylvia Hartmann, Hanneke Kluin-Nelemans, Olivier Hermine, Martin Dreyling, Wolfram Klapper

Blood (2018) 131 (4): 417–420.

https://doi.org/10.1182/blood-2017-07-797019

Published: 2018

Includes: Supplemental data

Journal Articles

DA-EPOCH-R Is an Effective Regimen in High Grade B-Cell Lymphoma Defined By Cell-of-Origin, Karyotype and BCL2 / MYC / BCL6 Status and Expression

Blood (2016) 128 (22): 1754.

https://doi.org/10.1182/blood.V128.22.1754.1754

Published: 2016

Journal Articles

Significance of a Critical Set of 11q Chromosome Aberrations for Diagnosis of MYC Negative Burkitt Lymphoma

Grzegorz Rymkiewicz, MD PhD, Magdalena Chechlinska, Beata Grygalewicz, Barbara Pienkowska-Grela, Katarzyna Blachnio, Zbigniew Bystydzienski, Joanna Romejko-Jarosinska, MD PhD, Beata Sledz-Gawronska, Michalina Zajdel, Katarzyna Domanska-Czyz, Renata Woroniecka, Kinga Sikorska-Mali, Jan Konrad Siwicki, Monika Prochorec-Sobieszek, MD PhD, Jan Walewski, MD PhDProf

Blood (2015) 126 (23): 2679.

https://doi.org/10.1182/blood.V126.23.2679.2679

Published: 2015

Journal Articles

Secondary Central Nervous System (CNS) Involvement in Patients Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL) during the First Line R-CHOP Treatment and after the End of Treatment

Joanna Romejko-Jarosinska, MD PhD, Michal Osowiecki, MD, Beata Ostrowska, MD PhD, Martyna Kotarska, MD, Katarzyna Domanska-Czyz, MD, Marcin Szymanski, MD, Lukasz Targonski, MD, Anna Borawska, MD PhD, Agnieszka Druzd-Sitek, MD PhD, Ewa Paszkiewicz-Kozik, MD PhD, Lidia Poplawska, Grzegorz Rymkiewicz, MD PhD, Jan Walewski, MD PhDProf

Blood (2015) 126 (23): 5040.

https://doi.org/10.1182/blood.V126.23.5040.5040

Published: 2015

Journal Articles

Tumor Cell Proliferation (Ki-67 Index) Overcomes Cytology and Growth Pattern As Prognostic Factor in Mantle-Cell Lymphoma – Results from Randomized Trials of the European MCL Network

Eva Hoster, PhD, Andreas Rosenwald, MD, Francoise Berger, MD PhD, Heinz-Wolfram Bernd, Sylvia Hartmann, Christoph Loddenkemper, Thomas Barth, Nicole Brousse, Stefano Pileri, Grzegorz Rymkiewicz, Roman Kodet, Michael Unterhalt, MD, Johanna C. Kluin-Nelemans, Olivier Hermine, MD PhD, Wolfgang Hiddemann, MD PhD, Martin H. Dreyling, Wolfram Klapper, MD

Blood (2014) 124 (21): 2977.

https://doi.org/10.1182/blood.V124.21.2977.2977

Published: 2014

Journal Articles

A recurrent 11q aberration pattern characterizes a subset of MYC -negative high-grade B-cell lymphomas resembling Burkitt lymphoma

Blood (2014) 123 (8): 1187–1198.

https://doi.org/10.1182/blood-2013-06-507996

Published: 2014

Includes: Supplemental data

Journal Articles

CHOP-R and High-Dose Methotrexate In The Primary CNS Lymphoma Revisited. 10-Year Experience and 92 Patients From a Single Institution

Beata Ostrowska, Michal Osowiecki, Katarzyna Domanska-Czyz, Joanna Romejko-Jarosinska, Ewa Paszkiewicz-Kozik, Lidia Poplawska, Grzegorz Rymkiewicz, Jaroslaw Stobiecki, Wojciech Michalski, Jan Walewski

Blood (2013) 122 (21): 3051.

https://doi.org/10.1182/blood.V122.21.3051.3051

Published: 2013

Journal Articles

CCND2 rearrangements are the most frequent genetic events in cyclin D1 − mantle cell lymphoma

Blood (2013) 121 (8): 1394–1402.

https://doi.org/10.1182/blood-2012-08-452284

Published: 2013

Includes: Supplemental data

Journal Articles

Fine Needle Aspiration Biopsy with Flow Cytometry Is a Reliable Method for Defining Immunophenotype of Prognostic Value in T Lymphoblastic Lymphoma.

Beata Ostrowska, Grzegorz Rymkiewicz, Joanna Romejko-Jarosinska, Katarzyna Blachnio, Katarzyna Domanska-Czyz, Wlodzimierz Osiadacz, Michal Osowiecki, Ewa Paszkiewicz-Kozik, Lidia Poplawska, Danuta Rozewska, Jaroslaw Stobiecki, Elzbieta Wojciechowska-Lampka, Wojciech Michalski, Jan Walewski

Blood (2009) 114 (22): 3928.

https://doi.org/10.1182/blood.V114.22.3928.3928

Published: 2009

Journal Articles

Vaccination with Lymphoma and Dendritic Cell Hybrids Intended as an Adjuvant Therapy for Lymphoma Patients - A Feasibility Study.

Sergiusz Markowicz, PhD, Anna Jakubowska-Mucka, MSc, Marzena Biernacka, MSc, Grzegorz Rymkiewicz, MD, Anna Borawska, MD, Irena Federowicz, MD, Danuta Rozewska, MD, Maria Sawadro-Rochowska, MSc, Hanna Polowniak-Pracka, MD, Michal Szymczyk, MD, Henryk Skurzak, MD, Zygmunt Pojda, MD, Jan Walewski, MD

Blood (2006) 108 (11): 5187.

https://doi.org/10.1182/blood.V108.11.5187.5187

Published: 2006

Journal Articles

WNT6 mRNA Is Overexpressed in Variuos Non-Hodgkin’s Lymphoma Cases with No Apparent Relation to Cyclin D1 Level.

Pawel M. Swoboda, Monika Gos, Grzegorz Rymkiewicz, Katarzyna Blachnio, Jan Walewski, Przemyslaw Janik

Blood (2005) 106 (11): 4663.

https://doi.org/10.1182/blood.V106.11.4663.4663

Published: 2005

Journal Articles

Flow Cytometry and Fluorescence In Situ Hybridization Are Methods of Choice for Routine Diagnosis of Mantle Cell Lymphoma.

Grzegorz Rymkiewicz, MD, Renata Woroniecka, MS, Katarzyna Blachnio, MS, Barbara Pienkowska-Grela, MD, PhD, Jan Walewski, MD, PhD

Blood (2005) 106 (11): 4659.

https://doi.org/10.1182/blood.V106.11.4659.4659

Published: 2005

NARROW

Idiopathic Multicentric Castleman Disease Interactive Disease Awareness and Educational Tool for Pathologists

Inhibition of PIM Kinases in Diffuse Large B-Cell Lymphoma Cells Targets MYC-Dependent Transcriptional Program, Increases CD20 Expression and Augments the Efficacy of Anti-CD20 Antibodies

Niveau, a Phase 3 Study for Pts with B- or T-Cell Aggressive Non-Hodgkin Lymphoma in First Relapse or Progression Not Eligible for High-Dose Chemotherapy (HDT), Testing Nivo lumab in Combination with G e mcitabine, Ox a liplatin (GemOx), Plus Rit u ximab (R) in Case of B-Cell Lymphoma

The whole-genome landscape of Burkitt lymphoma subtypes

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1 − mantle cell lymphoma

The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma

Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network

DA-EPOCH-R Is an Effective Regimen in High Grade B-Cell Lymphoma Defined By Cell-of-Origin, Karyotype and BCL2 / MYC / BCL6 Status and Expression

Significance of a Critical Set of 11q Chromosome Aberrations for Diagnosis of MYC Negative Burkitt Lymphoma

Secondary Central Nervous System (CNS) Involvement in Patients Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL) during the First Line R-CHOP Treatment and after the End of Treatment

Tumor Cell Proliferation (Ki-67 Index) Overcomes Cytology and Growth Pattern As Prognostic Factor in Mantle-Cell Lymphoma – Results from Randomized Trials of the European MCL Network

A recurrent 11q aberration pattern characterizes a subset of MYC -negative high-grade B-cell lymphomas resembling Burkitt lymphoma

CHOP-R and High-Dose Methotrexate In The Primary CNS Lymphoma Revisited. 10-Year Experience and 92 Patients From a Single Institution

CCND2 rearrangements are the most frequent genetic events in cyclin D1 − mantle cell lymphoma

Fine Needle Aspiration Biopsy with Flow Cytometry Is a Reliable Method for Defining Immunophenotype of Prognostic Value in T Lymphoblastic Lymphoma.

Vaccination with Lymphoma and Dendritic Cell Hybrids Intended as an Adjuvant Therapy for Lymphoma Patients - A Feasibility Study.

WNT6 mRNA Is Overexpressed in Variuos Non-Hodgkin’s Lymphoma Cases with No Apparent Relation to Cyclin D1 Level.

Flow Cytometry and Fluorescence In Situ Hybridization Are Methods of Choice for Routine Diagnosis of Mantle Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only